The novel biomedical technology developed by a Turkish engineering company offers license agreements for the treatment of upper respiratory tract associated diseases including Coronaviruses and Acute Respiratory Syndromes. The technology uses endoscopic procedures to biologically sterilize the upper tract and repair damaged tissues within the trachea through cold plasma therapy. License agreements are sought.
Solicite mayor información mencionando el código de referencia: https://www.eenclm.com/contacto/